{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:08:53Z","timestamp":1789157333836,"version":"build-2803163510"},"reference-count":27,"publisher":"Begell House","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Environ Pathol Toxicol Oncol"],"published-print":{"date-parts":[[2025]]},"abstract":"<p>Gastric cancer (GC) is a widespread cancerous disease with an unfavorable prognosis, linc01105 appears to have a significant connection with the development of GC, but the precise regulatory mechanism remains obscure. Real-time quantitative polymerase chain reaction (RT-qPCR) was utilized to determine the expression of linc01105, miR-650, and TCEA3. Proliferative capacity of GC cells was measured by CCK8. Cell apoptosis rates were analyzed via flow cytometry assessment. The invasive capability was assessed through the Transwell experiment. The targeted regulation of linc01105, miR-650, and TCEA3 was validated through dual luciferase reporter gene assay. Low expression of linc01105, high expression of miR-650, and low expression of TCEA3 were observed in GC tumor tissues and cell lines. High expression of linc01105 was correlated with a positive prognosis in GC patients. linc01105 affected GC cell function by miR-650\/TCEA3 axis. This study suggested that linc01105 may possess inhibitory functions towards GC. In addition, linc01105 may be a prognostic marker for GC.\n<\/p>","DOI":"10.1615\/jenvironpatholtoxicoloncol.2024054112","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T18:53:25Z","timestamp":1722624805000},"page":"85-94","source":"Crossref","is-referenced-by-count":1,"title":["The Long Non-Coding RNA linc01105 Inhibits Gastric Cancer Growth and Metastasis by Regulating the miR-650\/TCEA3 Axis"],"prefix":"10.1615","volume":"44","author":[{"given":"Qiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"613","reference":[{"key":"2","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49.","DOI":"10.3322\/caac.21660"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Song Z, Wu Y, Yang J, Yang D, Fang X. Progress in the treatment of advanced gastric cancer. Tumour Biol. 2017;39(7):1010428317714626.","DOI":"10.1177\/1010428317714626"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: A new paradigm. Cancer Res. 2017;77(15): 3965-81.","DOI":"10.1158\/0008-5472.CAN-16-2634"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Cao MX, Jiang YP, Tang YL, Liang XH. The crosstalk between lncRNA and microRNA in cancer metastasis: Orchestrating the epithelial-mesenchymal plasticity. Oncotarget. 2017;8(7):12472-83.","DOI":"10.18632\/oncotarget.13957"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Chen D, Sun Q, Cheng X, Zhang L, Song W, Zhou D, Lin J, Wang W. Genome-wide analysis of long noncoding RNA (lncRNA) expression in colorectal cancer tissues from patients with liver metastasis. Cancer Med. 2016;5(7):1629-39.","DOI":"10.1002\/cam4.738"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Luo Y, Zheng S, Wu Q, Wu J, Zhou R, Wang C, Wu Z, Rong X, Huang N, Sun L, Bin J, Liao Y, Shi M, Liao W. Long noncoding RNA (lncRNA) EIF3J-DT induces chemoresistance of gastric cancer via autophagy activation. Autophagy. 2021;17(12):4083-101.","DOI":"10.1080\/15548627.2021.1901204"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Zhu Y, Zhou B, Hu X, Ying S, Zhou Q, Xu W, Feng L, Hou T, Wang X, Zhu L, Jin H. LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability. Clin Transl Med. 2022;12(1):e703.","DOI":"10.1002\/ctm2.703"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Lv Z, Sun L, Xu Q, Xing C, Yuan Y. Joint analysis of lncRNA m(6)A methylome and lncRNA\/mRNA expression profiles in gastric cancer. Cancer Cell Int. 2020:20:464.","DOI":"10.1186\/s12935-020-01554-8"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Ye M, Ma J, Liu B, Liu X, Ma D, Dong K. linc01105 acts as an oncogene in the development of neuroblastoma. Oncol Rep. 2019;42(4):1527-38.","DOI":"10.3892\/or.2019.7257"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Luo H, Xu C, Le W, Ge B, Wang T. lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150. J Cell Biochem. 2019;120(8):13487-93.","DOI":"10.1002\/jcb.28622"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Su Y, Zheng Q, Zhu L, Gu X, Lu J, Li L. Functions and underlying mechanisms of miR-650 in human cancers. Cancer Cell Int. 2022;22(1):132.","DOI":"10.1186\/s12935-022-02551-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Kazim N, Adhikari A, Oh TJ, Davie J. The transcription elongation factor TCEA3 induces apoptosis in rhabdomyosarcoma. Cell Death Dis. 2020;11(1):67.","DOI":"10.1038\/s41419-020-2258-x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Cha Y, Kim DK, Hyun J, Kim SJ, Park KS. TCEA3 binds to TGF-beta receptor I and induces Smad-independent, JNK-dependent apoptosis in ovarian cancer cells. Cell Signal. 2013;25(5):1245-51.","DOI":"10.1016\/j.cellsig.2013.01.016"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Urh K, Zidar N, Tomazic A, Bostjancic E. Intra\u00e2\u0080\u0091tumor heterogeneity of cancer stem cell\u00e2\u0080\u0091related genes and their potential regulatory microRNAs in metastasizing colorectal carcinoma. Oncol Rep. 2022;48(5):193.","DOI":"10.3892\/or.2022.8408"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Song J, Ye A, Jiang E, Yin X, Chen Z, Bai G, Zhou Y, Liu J. Reconstruction and analysis of the aberrant lncRNA-miRNA-mRNA network based on competitive endogenous RNA in CESC. J Cell Biochem. 2018;119(8):6665-73.","DOI":"10.1002\/jcb.26850"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Guo W, You X, Xu D, Zhang Y, Wang Z, Man K, Wang Z, Chen Y. PAQR3 enhances Twist1 degradation to suppress epithelial-mesenchymal transition and metastasis of gastric cancer cells. Carcinogenesis. 2016;37(4):397-407.","DOI":"10.1093\/carcin\/bgw013"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Zhang G, Li S, Lu J, Ge Y, Wang Q, Ma G, Zhao Q, Wu D, Gong W, Du M, Chu H, Wang M, Zhang A, Zhang Z. LncRNA MT1JP functions as a ceRNA in regulating  FBXW7 through competitively binding to miR-92a-3p in gastric cancer. Mol Cancer. 2018;17(1):87.","DOI":"10.1186\/s12943-018-0829-6"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Tang W, Dong K, Li K, Dong R, Zheng S. MEG3, HCN3 and linc01105 influence the proliferation and apoptosis of neuroblastoma cells via the HIF-1a and p53 pathways. Sci Rep. 2016:6:36268.","DOI":"10.1038\/srep36268"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Fang D, Ou X, Sun K, Zhou X, Li Y, Shi P, Zhao Z, He Y, Peng J, Xu J. m6A modification-mediated lncRNA TP53TG1 inhibits gastric cancer progression by regulating CIP2A stability. Cancer Sci. 2022;113(12):4135-50.","DOI":"10.1111\/cas.15581"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Lu Q, Guo Q, Xin M, Lim C, Gamero AM, Gerhard GS, Yang L. LncRNA TP53TG1 promotes the growth and migration of hepatocellular carcinoma cells via activation of ERK signaling. Noncoding RNA. 2021;7(3):52.","DOI":"10.3390\/ncrna7030052"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Tie W, Ge F. MALAT1 inhibits proliferation of HPV16-positive cervical cancer by sponging miR-485-5p to promote expression of MAT2A. DNA Cell Biol. 2021;40(11): 1407-17.","DOI":"10.1089\/dna.2020.6205"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Wu Q, Meng W Y, Jie Y, Zhao H. LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p\/HMGB1 axis. J Cell Physiol. 2018;233(9):6750-7.","DOI":"10.1002\/jcp.26383"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA Jr, Sjoblom T, Barad O, Bentwich Z, Szafranska AE, Labourier E, Raymond CK, Roberts BS, Juhl H, Kinzler KW, Vogelstein B, Velculescu VE. The colorectal microRNAome. Proc Natl Acad Sci U S A. 2006;103(10): 3687-92.","DOI":"10.1073\/pnas.0511155103"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Tang X, Ding Y, Wang X, Wang X, Zhao L, Bi H. miR-650 promotes non-small cell lung cancer cell proliferation and invasion by targeting ING4 through Wnt-1\/B-catenin pathway. Oncol Lett. 2019;18(5):4621-8.","DOI":"10.3892\/ol.2019.10805"},{"key":"26","unstructured":"Xu L, Yu QW, Fang SQ, Zheng YK, Qi JC. MiR-650 inhibits the progression of glioma by targeting FAM83F. Eur Rev Med Pharmacol Sci. 2018;22(23):8391-8."},{"key":"27","doi-asserted-by":"crossref","unstructured":"Orlandella FM, Mariniello RM, Iervolino PLC, Imperlini E, Mandola A, Verde A, De Stefano AE, Pane K, Franzese M, Esposito S, Basolo F, Orru S, Salvatore G. miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA. Endocrine. 2019;65(3):582-94.","DOI":"10.1007\/s12020-019-01910-3"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Li J, Jin Y, Pan S, Chen Y, Wang K, Lin C, Jin S, Wu J. TCEA3 attenuates gastric cancer growth by apoptosis induction. Med Sci Monit. 2015;21:3241-6.","DOI":"10.12659\/MSM.895860"}],"container-title":["Journal of Environmental Pathology, Toxicology and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dl.begellhouse.com\/download\/article\/57e0b5d723067ce0\/JEP(T)-54112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T06:55:15Z","timestamp":1749624915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dl.begellhouse.com\/journals\/0ff459a57a4c08d0,0b717b2d411c7d59,57e0b5d723067ce0.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1615\/jenvironpatholtoxicoloncol.2024054112","relation":{},"ISSN":["0731-8898"],"issn-type":[{"value":"0731-8898","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}